Nanobiotix SA
NBTX20.850USD
-0.180-0.86%
收盘 02/06, 16:00（美东）报价延迟15分钟
1.01B总市值
亏损市盈率 TTM
关于 Nanobiotix SA 公司
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Nanobiotix SA简介
公司代码NBTX
公司名称Nanobiotix SA
上市日期Oct 29, 2012
CEOLevy (Laurent)
员工数量108
证券类型Depository Receipt
年结日Oct 29
公司地址60 rue de Wattignies
城市PARIS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家France
邮编75012
电话33140260470
网址https://www.nanobiotix.com
公司代码NBTX
上市日期Oct 29, 2012
CEOLevy (Laurent)
Nanobiotix SA公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 1月6日 周二
更新时间: 1月6日 周二
持股股东
股东类型
持股股东
持股股东
占比
Johnson & Johnson Innovation-JJDC, Inc.
11.66%
Geode Capital Management, L.L.C.
0.02%
Optiver Holding B.V.
0.01%
其他
88.30%
持股股东
持股股东
占比
Johnson & Johnson Innovation-JJDC, Inc.
11.66%
Geode Capital Management, L.L.C.
0.02%
Optiver Holding B.V.
0.01%
其他
88.30%
股东类型
持股股东
占比
Venture Capital
11.66%
Investment Advisor/Hedge Fund
0.02%
Investment Advisor
0.02%
其他
88.30%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
26
5.64M
11.71%
-3.12M
2025Q3
27
5.65M
11.71%
-4.13M
2025Q2
25
5.76M
12.15%
-4.19M
2025Q1
25
5.76M
12.15%
-4.19M
2024Q4
25
6.07M
12.79%
-4.24M
2024Q3
21
6.42M
13.54%
-3.89M
2024Q2
22
9.30M
19.73%
-1.04M
2024Q1
21
9.31M
19.76%
-988.94K
2023Q4
21
9.28M
19.68%
+1.01M
2023Q3
16
4.47M
12.36%
+481.67K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Johnson & Johnson Innovation-JJDC, Inc.
5.62M
11.66%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
10.18K
0.02%
--
--
Sep 30, 2025
Optiver Holding B.V.
5.36K
0.01%
+5.36K
--
Sep 30, 2025
Morgan Stanley & Co. International Plc
2.38K
0%
-2.92K
-55.13%
Sep 30, 2025
UBS Financial Services, Inc.
2.16K
0%
-2.26K
-51.09%
Sep 30, 2025
EverSource Wealth Advisors, LLC
514.00
0%
-3.00
-0.58%
Sep 30, 2025
BNP Paribas Securities Corp. North America
400.00
0%
-361.00
-47.44%
Sep 30, 2025
GAMMA Investing LLC
229.00
0%
+229.00
--
Dec 31, 2025
RBC Capital Markets Wealth Management
125.00
0%
--
--
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
33.00
0%
--
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Biotechnology ETF
0%
iShares Biotechnology ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
